Kazal-type serine protease inhibitor 13 (SPINK13) was first screened and discovered by our group from hepatocellular carcinoma (HCC) HepG2 cells in 2005 and named Hespintor, and the sequence was submitted to GenBank (DQ438947) in March 2006 and officially named SPINK13 in June 2018 [4]. This evidence concerns the gene SPINK13 and hepatocellular carcinoma.